Skip to Main Content

Paper Details

A Novel Acquired Exon 20 EGFR M766Q Mutation in Lung Adenocarcinoma Mediates Osimertinib Resistance but is Sensitive to Neratinib and Poziotinib.
J Thorac Oncol
23
2019
Author NameAffiliation
Stephen K BurleyRutgers Cancer Institute of New Jersey, The State University of New Jersey, New Jersey Institute for Quantitative Biomedicine
Brinda VallatInstitute for Quantitative Biomedicine, The State University of New Jersey
  • 1 - 2

Datasets

Release 1.2